Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Houston

Showing results (311-320 of 316) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 316 results.
Research and Practice in Thrombosis and Haemostasis|July 4, 2025
Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trialSylvain A Lother, Wen Teng, Olawale Ayilara, et al.
Clinical Trials (London, England)|August 21, 2020
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trialBrett L Houston, Patrick R Lawler, Ewan C Goligher, et al.
Sensors (Basel, Switzerland)|May 15, 2019
Intercomparison of Small Unmanned Aircraft System (sUAS) Measurements for Atmospheric Science during the LAPSE-RATE CampaignLindsay Barbieri, Stephan T Kral, Sean C C Bailey, et al.
JACC. Advances|June 28, 2024
Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19Lucas C Godoy, Matthew D Neal, Ewan C Goligher, et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19, , , et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19, , , et al.
Pageof 32

Showing results (311-320 of 316) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 316 results.
Research and Practice in Thrombosis and Haemostasis|July 4, 2025
Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trialSylvain A Lother, Wen Teng, Olawale Ayilara, et al.
Clinical Trials (London, England)|August 21, 2020
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trialBrett L Houston, Patrick R Lawler, Ewan C Goligher, et al.
Sensors (Basel, Switzerland)|May 15, 2019
Intercomparison of Small Unmanned Aircraft System (sUAS) Measurements for Atmospheric Science during the LAPSE-RATE CampaignLindsay Barbieri, Stephan T Kral, Sean C C Bailey, et al.
JACC. Advances|June 28, 2024
Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19Lucas C Godoy, Matthew D Neal, Ewan C Goligher, et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19, , , et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19, , , et al.
Pageof 32